All the evidence suggests that miR-497 and miR-1246 can behave as biomarkers with excellent sensitivity and specificity that might be empowered for the early diagnosis of HCC, and the diagnostic efficacy can be even higher when AFP is incorporated into the combination. The gene discussed is AFP; the disease is hepatocellular carcinoma.